Table 3.

Baseline patient characteristics grouped by worsening renal function

Variable	Worsening Renal Function		p Value
	No (n=93)	Yes (n=48)
Age (years)	63 ± 17	60 ± 14	0.32
African American	73 (79%)	36 (75%)	0.64
Male	44 (47%)	29 (60%)	0.14
Systolic blood pressure (mmHg)	148 ± 33	147 ± 31	0.9
Heart rate (beats per minute)	82 ± 16	81 ± 16	0.63
General medical service	71 (77%)	36 (75%)	0.77
Volume overload on chest X-ray	44 (71%)	24 (65%)	0.53
Hemoglobin (g/dL)	12.2 ± 2.3	12.0 ± 1.9	0.55
Detectable troponin I	25 (27%)	10 (21%)	0.43
Blood urea nitrogen (mg/dL)	21 (15 to 29)	21 (14 to 32)	0.65
Serum sodium (mg/dL)	139.4 ± 5.5	138.9 ± 4.0	0.58
Admission glomerular filtration rate (mL/min/1.73m2)	68.5 ± 27.0	53.5 ± 26.6	0.002*
Admission serum creatinine (mg/dL)	1.2 (1.0 to 1.5)	1.3 (1.0 to 1.9)	0.29
B-type natriureetic peptide (pg/dL)	1679 (924 to 2518)	1368 (961 to 2925)	0.92
Maximum diuretic dose (mg/day)	80 (80 to 160)	120 (80 to 200)	0.14
Thiazide use	10 (11%)	9 (19%)	0.19
Net fluid out (L)	3.9 (1.7 to 7.2)	3.9 (0.5 to 5.3)	0.23
Length of stay (days)	5 (3.5 to 6.5)	5 (4.0 to 7.0)	0.58
Day peak creatinine (days)	3 (2.0 to 4.0)	4 (3.0 to 5.0)	0.03*
Ejection fraction (%)	25 (15 to 53)	23 (15 to 40)	0.85
Early peak mitral inflow velocity/early peak annular tissue velocity (septal)	19.0 ± 10.4	17.2 ± 8.5	0.34
Early peak mitral inflow velocity/early peak annular tissue velocity (lateral)	12.2 ± 6.8	12.5 ± 6.2	0.81
Cardiac output (L/min)	4.5 ± 1.9	4.7 ± 1.6	0.44
Lack of inspiratory inferior vena cava collapse	19 (20%)	3 (6.3%)	0.03*
Left atrial size (cm)	4.9±0.7	4.6±0.7	0.1
Moderate or severe right ventricle dilation	35 (39%)	7 (15%)	0.004*
Moderate or severe right ventricle dysfunction	50 (54%)	9 (19)%	<0.001*
Right Ventricular fractional area change (%)	28.6 (21.5 to 36.9)	35.3 (26.0 to 41.9)	0.007*
Tricuspid annular plane systolic excursion (cm)	1.5 (1.2, 1.7)	1.8 (1.4, 2.0)	0.002*
Moderate or severe tricuspid regurgitation	46 (50%)	20 (42%)	0.38

^*represents a significant p value.